Coverage determination for oncology drugs can be delayed for months after regulatory approval, a new study suggests. Coverage determination for oncology drugs can be delayed for months after ...

The RAPID pathway could cut the wait for Medicare coverage from over a year to about 2 months after FDA market authorization ...

Faster Medicare Coverage. The Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration ...

On September 9, 2025, the Government Accountability Office (GAO) published a report titled “National Coverage Determinations Are Generally Timely, but Improvements Are Needed” (the Report). CMS makes ...

CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product ...

The Centers for Medicare & Medicaid Services (CMS) uses coverage determinations to decide how Medicare should cover treatments, services, and items. These rules usually apply nationwide. The CMS ...

Medicare, Medicaid, and major insurers are updating continuous glucose monitor (CGM) coverage to align with defined clinical criteria and new authorization processes. UnitedHealthcare will require ...

LONDON and NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on June 13, 2024 Medicare issued a final Local Coverage Determination ("LCD") for the ...

IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular ...

Patent Issued for Use determination risk coverage datastructure for on-demand and increased efficiency coverage detection and rebalancing apparatuses, methods and systems (USPTO 11790454): Bind ...